Quality of dorzolamide hydrochloride and timolol maleate containing eye drops distributed online

Quality of dorzolamide hydrochloride and timolol maleate containing eye drops distributed online

Patient safety risks associated with the online purchase of medications, especially in case of ophthalmic preparations, are significant. Our study aimed to carry out quality assessment of dorzolamide hydrochloride (DZA) and timolol maleate (TIM) eye drops preserved with benzalkonium chloride (BAC) v...

Full description

Bibliographic Details
Main Authors:	Sára Merczel, Róbert György Vida, Tamás Tasi, András Fittler, Lajos Botz
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Saudi Pharmaceutical Journal
Subjects:	Patient safety Substandard and falsified medicines Ophthalmic medical products Eye drop Quality assessment Online market
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319016423001007

Similar Items

Falsified and substandard medicines trafficking: A wakeup call for the African continent
by: Yusuf Hassan Wada, et al.
Published: (2022-06-01)

Evaluation of Seven Different Brands of Metformin Hydrochloride Tablets Available in the Market in Gondar City, Ethiopia
by: Flatie Alemu A, et al.
Published: (2024-02-01)

Effects of timolol maleate eye drops on experimentally dilated cardiomyopathy and healthy rabbits
by: Mitsuhiro Isaka, et al.
Published: (2021-08-01)

Analysis of pharmacovigilance databases for spontaneous reports of adverse drug reactions related to substandard and falsified medical products: A descriptive study
by: Kevin Pozsgai, et al.
Published: (2022-09-01)

The role of pharmacists in eliminating counterfeit medicines in Nigeria
by: Obi Peter Adigwe
Published: (2023-08-01)

Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
by: Kathryn D. Jackson, et al.
Published: (2020-07-01)

Clinical study of Fuming tablet combined with Timolol Maleate eye drops in the treatment of open angle glaucoma
by: Jin Li, et al.
Published: (2019-10-01)

Substandard and Falsified Medicines in Myanmar
by: Mirai Sakuda, et al.
Published: (2020-03-01)

A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
by: Daariimaa Khurelbat, et al.
Published: (2020-05-01)

Medicine recalls in Saudi Arabia: a retrospective review of drug alerts (January 2010–January 2019)
by: Bushra T. AlQuadeib, et al.
Published: (2020-11-01)

Global scenario of counterfeit antimalarials: A potential threat
by: Taruna Arora, et al.
Published: (2019-01-01)

Polymeric ocular hydrogels and ophthalmic inserts for controlled release of timolol maleate
by: Vinod Singh, et al.
Published: (2011-01-01)

Pharmacodynamic equivalence study of two preparations of eye drops, containing dorzolamide in healthy volunteers
by: Gatchev Emil M., et al.
Published: (2016-01-01)

Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems
by: Lukas Roth, et al.
Published: (2018-11-01)

Fake anabolic androgenic steroids on the black market – a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature
by: Raphael Magnolini, et al.
Published: (2022-07-01)

Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence
by: Ana Castro-Balado, et al.
Published: (2023-11-01)

Developing a framework regarding a complex risk based methodology in the evaluation of hazards associated with medicinal products sourced via the internet
by: Róbert György Vida, et al.
Published: (2020-12-01)

Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community
by: Stanislav Kniazkov, et al.
Published: (2020-12-01)

Pharmacists’ perceptions and attitudes toward drug importation into the State of Florida
by: John B. Hertig, et al.
Published: (2021-12-01)

Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review
by: Kari A. Griffore, et al.
Published: (2023-11-01)

Global landscape assessment of screening technologies for medicine quality assurance: stakeholder perceptions and practices from ten countries
by: Lukas Roth, et al.
Published: (2018-04-01)

Regulatory framework in Pakistan: situation analysis of medicine quality and future recommendations
by: Huma Rasheed, et al.
Published: (2019-12-01)

Tackling the blind spot of poor-quality medicines in Universal Health Coverage
by: E. S. F. Orubu, et al.
Published: (2020-12-01)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
by: Waleed M. Sweileh
Published: (2021-09-01)

The Development of Super-Saturated Rebamipide Eye Drops for Enhanced Solubility, Stability, Patient Compliance, and Bioavailability
by: Dong-Jin Jang, et al.
Published: (2023-03-01)

Efficacy Evaluation of 755-nm Long-Pulse Alexandrite Laser Combined with 0.5% Timolol Maleate Eye Drops in the Treatment of Thicker Infantile Hemangioma
by: Wu J, et al.
Published: (2021-11-01)

A study of effectiveness and adherence between fixed combination dorzolamide /timolol maleate and non-fixed dorzolamide and timolol xe in open angle glaucoma
by: Rasid, Noor Khairul
Published: (2015)

Post marketing surveillance of selected veterinary medicines in Tanzania mainland
by: Adam M. Fimbo, et al.
Published: (2022-06-01)

Quality, availability and storage conditions of oxytocin and misoprostol in Malawi
by: Nhomsai Hagen, et al.
Published: (2020-03-01)

The Yijing Buyang Huanwu Decoction combined with timolol maleate in the treatment of POAG
by: Xiao-Rong Zhang, et al.
Published: (2021-02-01)

Clinical Application and Efficacy of Silver Drug in Ophthalmology: A Literature Review and New Formulation of EYE Drops with Drug Silver (I) Complex of Metronidazole with Improved Dosage Form
by: Arleta Waszczykowska, et al.
Published: (2021-02-01)

Safety, tolerability, and efficacy of fixed combination therapy with dorzolamide hydrochloride 2% and timolol maleate 0.5% in glaucoma and ocular hypertension
by: Nicholas P Bell, et al.
Published: (2010-11-01)

Verification of the active pharmaceutical ingredient in tablets using a low-cost near-infrared spectrometer
by: Julia Gabel, et al.
Published: (2023-12-01)

Combating Sale of Counterfeit and Falsified Medicines Online: A Losing Battle
by: Kah Seng Lee, et al.
Published: (2017-05-01)

Quality of selected anti-retroviral medicines: Tanzania Mainland market as a case study
by: Sophia Mziray, et al.
Published: (2021-08-01)

NIGHTMARES FROM TOPICAL TIMOLOL EYE DROPS: A CASE REPORT
by: Yousaf Jamal Mahsood, et al.
Published: (2020-09-01)

Clinical study of 3g/L sodium hyaluronate eye drops with bromhexine hydrochloride tablets for dry eye
by: Hui-Qun Xu
Published: (2018-04-01)

Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop
by: Xurxo García-Otero, et al.
Published: (2021-01-01)

Effectiveness of autologous serum eye drops in the treatment of corneoconjunctival burns
by: Yanier Serrano-García, et al.
Published: (2019-05-01)

Risk factors for periorbital dermatitis in patients using dorzolamide/timolol eye drops
by: Myungjin Kim, et al.
Published: (2021-09-01)